Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Financing Activities: 2020-2024

Historic Cash from Financing Activities for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $5.8 million.

  • iSpecimen's Cash from Financing Activities rose 508.11% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 444.81%. This contributed to the annual value of $5.8 million for FY2024, which is 8108.47% up from last year.
  • iSpecimen's Cash from Financing Activities amounted to $5.8 million in FY2024, which was up 8,108.47% from $70,889 recorded in FY2023.
  • In the past 5 years, iSpecimen's Cash from Financing Activities registered a high of $38.7 million during FY2021, and its lowest value of -$3.4 million during FY2022.
  • Over the past 3 years, iSpecimen's median Cash from Financing Activities value was $70,889 (recorded in 2023), while the average stood at $822,810.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 108.83% in 2022, then skyrocketed by 8,108.47% in 2024.
  • Over the past 5 years, iSpecimen's Cash from Financing Activities (Yearly) stood at $2.0 million in 2020, then soared by 1,806.01% to $38.7 million in 2021, then slumped by 108.83% to -$3.4 million in 2022, then spiked by 102.07% to $70,889 in 2023, then spiked by 8,108.47% to $5.8 million in 2024.